GIM
FLXN

Granahan Investment Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Granahan Investment Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,233,194
Closed -$7.52M – 207
2021
Q3 		$7.52M Sell
1,233,194
-180,109
-13% -$1.12M 0.14% 130
2021
Q2 		$11.6M Buy
1,413,303
+364,222
+35% +$3.1M 0.22% 103
2021
Q1 		$9.39M Sell
1,049,081
-143,667
-12% -$1.65M 0.2% 97
2020
Q4 		$13.8M Sell
1,192,748
-64,942
-5% -$755K 0.31% 75
2020
Q3 		$13.1M Buy
1,257,690
+481,877
+62% +$5.9M 0.44% 70
2020
Q2 		$10.2M Buy
775,813
+70,067
+10% +$727K 0.37% 77
2020
Q1 		$5.55M Buy
+705,746
New +$10.6M 0.3% 86

Granahan Investment Management's FLXN Position: Q4 2021 in Review

Granahan Investment Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 1,233,194 shares — an estimated $7.52M sold.

Granahan Investment Management first reported a position in FLXN in Q1 2020 and held it in 7 quarters. The position peaked at $13.8M in Q4 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • Granahan Investment Management reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Granahan Investment Management sold 1,233,194 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $7.52M.
  • Granahan Investment Management first reported a position in Flexion Therapeutics, Inc. in Q1 2020 and held it in 7 quarters.
  • Granahan Investment Management's Flexion Therapeutics, Inc. position peaked at $13.8M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.